Abbott Laboratories (ABT) SEC Filing 8-K Material Event for the period ending Thursday, September 15, 2022

Abbott Laboratories

CIK: 1800 Ticker: ABT

View differences made from one to another to evaluate Abbott Laboratories's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Abbott Laboratories.


Assess how Abbott Laboratories's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Abbott Laboratories's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Material Contracts, Statements, Certifications & more

Abbott Laboratories provided additional information to their SEC Filing as exhibits

Ticker: ABT
CIK: 1800
Form Type: 8-K Corporate News
Accession Number: 0001104659-22-100434
Submitted to the SEC: Thu Sep 15 2022 4:03:07 PM EST
Accepted by the SEC: Thu Sep 15 2022
Period: Thursday, September 15, 2022
Industry: Pharmaceutical Preparations
  1. Bylaw Change
  2. Event for Officers
  3. Financial Exhibit

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: